Overview A global pharmaceutical company was facing regulatory investigations across multiple jurisdictions due to whistleblower allegations concerning corruption within its China operations. The allegations suggested
Overview A global pharmaceutical company with extensive operations in China faced allegations of severe FCPA violations, involving fraudulent expense claims by sales representatives, third-party travel
Overview H&A conducted a targeted intellectual property (IP) investigation for a private Chinese fashion brand (the Client) concerned about the risk of IP leaks to
Overview A major European industrial gas manufacturer engaged H&A to investigate allegations of conflict of interest involving a business development manager at its China entity.
Copyright © 2025 Hill & Associates. All rights reserved.
